INSPECS Group plc (AIM:SPEC)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 87.00
-1.50 (-1.69%)
Nov 6, 2026, 1:21 PM GMT
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 94.98 million as of November 6, 2026. It is the 23,241st most valuable company in the world and the 513th biggest in the United Kingdom. Its market cap has increased by 53.15% in one year.
Market Cap
94.98M
Enterprise Value
123.90M
Revenue
193.23M
Global Rank
Country Rank
#513 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 94.98M, a decrease of -31.15%. That is a compound annual growth rate of -5.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 95.53M | 31.41% |
| Dec 31, 2025 | 72.70M | 57.14% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.06B |
| GSK plc | 75.77B |
| Haleon | 29.80B |
| Smith & Nephew | 9.72B |
| EKF Diagnostics Holdings | 104.49M |
| Bioventix | 101.88M |
| Scancell Holdings | 101.83M |
| Venture Life Group | 82.75M |